Patient Guide: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 55 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05979441
Status: ENROLLING_BY_INVITATION
Condition: Muscular Diseases, Dermatomyositis, Myositis, Polymyositis
Phase: PHASE3

Where You Can Participate

This study is available at 55 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Beverly Hills, California
  • • Orange, California
  • • And 52 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy - Join Clinical Trial NCTNCT05979441

How to Join This Clinical Trial - NCTNCT05979441

Learn how to participate in this PHASE3 trial studying an investigational therapy for Muscular Diseases, Dermatomyositis, Myositis, Polymyositis. Current status: ENROLLING_BY_INVITATION.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Muscular Diseases, Dermatomyositis, Myositis, Polymyositis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Muscular Diseases, Dermatomyositis, Myositis, Polymyositis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ENROLLING_BY_INVITATION
Study Identifier
NCTNCT05979441 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 55 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85028 - United States

Status: Contact for availability

Clinical Research Site

Beverly Hills, California 90039 - United States

Status: Contact for availability

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Florida 32610 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: Contact for availability

Clinical Research Site

Great Neck, New York 11021 - United States

Status: Contact for availability

Clinical Research Site

Portland, Oregon 97239 - United States

Status: Contact for availability

And 45 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Muscular Diseases, Dermatomyositis, Myositis, Polymyositis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships